References
- Dyall J, Gross R, Kindrachuk J, et al. Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs. 2017 Dec;77(18):1935–1966.
- Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269–271.
- Antimalarial drug confirmed effective on COVID-19 [Internet]. China: the state council of the people’s Republic of China; 2020 Mar 17. [cited 2020 May 28]. Available from: http://english.www.gov.cn/statecouncil/ministries/202002/17/content_WS5e4a944dc6d0595e03c20f35.html
- Gao J, Tian Z, Breakthrough: YX. Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16;14(1):72–73.
- Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;ciaa237. doi: 10.1093/cid/ciaa237.
- Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020 Mar;55(3):105923.
- Raoult D Coronavirus:versune sortie de crise? [Video]. IHU Méditerranée-Infection: youTube [Internet]; 2020 Feb 25 cited 2020 May 27. Available from: https://www.youtube.com/watch?v=8L6ehRif-v8&feature=youtu.be
- Musk E “Maybe worth considering chloroquine for C19“. [Internet]. @elonmusk: Twitter; 2020 Mar 16. cited 2020 May 27. Available from: https://twitter.com/elonmusk/status/1239650597906898947?s=20
- Edney A Trump Touts Drug That FDA Says Isn’t Yet Approved for Virus [News Article]. Prognosis: Bloomberg.com [Internet]; 2020 Mar 19 updated Mar 19, 2020, 4:12 PM EDT 2020 Mar 19. Available from: https://www.bloomberg.com/news/articles/2020-03-19/trump-touts-malaria-drug-as-potential-coronavirus-treatment
- Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20;105949. doi: 10.1016/j.ijantimicag.2020.105949.
- Kim AHJ, Sparks JA, Liew JW, et al. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 Jun 16;172(12):819–821.
- Trump DJ “HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game changers in the history of medicine. The FDA has moved mountains - Thank You! Hopefully they will BOTH (H works better with A, International Journal of Antimicrobial Agents) …”. [Internet]. @realDonaldTrump: Twitter. 2020 Mar 21. cited 2020 May 27 Available from: https://twitter.com/realDonaldTrump/status/1241367239900778501?s=20.
- Horn A Online pharmacy saw a ‘panic-driven’ boom in drug touted by Trump. [Internet]: NPR.com; updated 2020 May 14; cited 2020 May 14; cited 2020 May 14; cited 2020 May 14; cited 2020 May 26. Available from: https://www.npr.org/sections/coronavirus-live-updates/2020/05/14/855841849/online-pharmacy-saw-a-panic-driven-boom-in-drug-touted-by-trump
- Mahase E. Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence. BMJ. 2020 Mar;23(368):m1166.
- COVID-19: Hydroxychloroquine, Chloroquine, and Azithromycin [Internet]. National Alliance of State Pharmacy Associations; updated 2020 Apr 13; cited 2020 Apr 13; cited 2020 Apr 13; cited 2020 May 13; cited 2020 May 27. Available from: https://naspa.us/resource/hydroxychloroquine-chloroquine-and-azithromycin/
- EULAR president: application of anti-malarials to tackle COVID-19 raises vital issues for rheumatic disease community in Europe 2020. [Internet]. Kilchberg, Switzerland: EULAR; 2020 Apr 3 cited 2020 May 27. Available from: https://www.eular.org/sysModules/obxContent/files/www.eular.2015/1_42291DEB-50E5-49AE-5726D0FAAA83A7D4/eular_president_application_of_anti_malarials_to_tackle_covid_19_raises_vital_issues_for_rheumatic_disease_community_in_europe(1).pdf
- American College of Rheumatology. Guiding principles from the American College of Rheumatology for scarce resource allocation during the COVID-19 pandemic: the case of hydroxychloroquine 2020. [Internet]. [ updated 2020 Apr 22]. [cited 2020 May 28]. Available from: https://www.rheumatology.org/Portals/0/Files/Guiding-Principles-Scarce-Resource-Allocation-During-Covid-19.pdf
- BFARM. Hydroxychloroquin - Sicherstellung der Versorgung von chronisch kranken Patientinnen und Patienten in den zugelassenen Indikationen. [Internet]. Germany: Bundesinstitut für Arzneimittel und Medizinprodukte; updated 2020 Mar 4; cited 2020 May 27]; Letter 2020 Mar 4; cited 2020 Mar 4; cited 2020 May 4; cited 2020 May 27. Available from: https://www.bfarm.de/DE/Service/Presse/Themendossiers/Coronavirus/Anlagen/Off_Label_Use_Hydroxychloroquin.pdf;jsessionid=0F3476A70525B464B743E623F671C154.2_cid507?__blob=publicationFile&v=1
- Statement: Lupus Foundation of America urges manufacturers of hydroxychloroquine and chloroquine to ensure supply to treat lupus. Lupus Foundation of America [Internet]. [Internet]; 2020 Mar 23 cited 2020 May 27. Available from: https://www.lupus.org/news/lupus-foundation-statement-manufacturers-hydroxychloroquine-chloroquine
- Waldrop T, Alsup D, McLaughlin E Fearing coronavirus, Arizona man dies after taking a form of chloroquine used to treat aquariums [Internet]: CNN; updated 2020 Mar 25; cited 2020 Mar 25; cited 2020 Mar 25; cited 2020 May 25; cited 2020 May 27. Available from: https://www.cnn.com/2020/03/23/health/arizona-coronavirus-chloroquine-death/index.html
- Sanders T, Armstrong D, Kofman A Doctors Are Hoarding Unproven Coronavirus Medicine by Writing Prescriptions for Themselves and Their Families [Internet]. ProPublica; [ updated 2020, Mar 24]. [cited 2020 May 28]. Available from: https://www.propublica.org/article/doctors-are-hoarding-unproven-coronavirus-medicine-by-writing-prescriptions-for-themselves-and-their-families
- Gautret P, Lagier J-C, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020 Mar-Apr;34:101663. doi: 10.1016/j.tmaid.2020.101663. Epub 2020 Apr 11.
- Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. 2020. [cited 2020 May 28]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3
- Yazdany J, Kim AHJ. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: what Every Clinician Should Know. Ann Intern Med. 2020 Jun 2;172(11):754–755.
- Romo V COVID-19 Patients Given Unproven Drug In Texas Nursing Home In ‘Disconcerting’ Move [Internet]: NPR.org; updated 2020 Apr 10; cited 2020 Apr 10; cited 2020 Apr 10; cited 2020 May 10; cited 2020 May 27. Available from: https://www.npr.org/2020/04/10/830348837/covid-19-patients-given-unproven-drug-in-texas-nursing-home-garnering-criticism
- Graef ER, Liew JW, Putman MS, et al. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 Jun;79(6):734–736.
- U.S. Food and Drug Administration. Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease [Internet] 2020 Mar 28 [cited 2020 May 26]; Government Letter. Available from: https://www.fda.gov/media/136534/download
- U.S. Food and Drug Administration. FDA Drug Shortages [Internet]; cited 2020 Mar 31. Available from: https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
- Remarks by President Trump, Vice President Pence, and Members of the Coronavirus Task Force in Press Briefing [Internet]. The White House April; 4, 2020 [cited 2020 May 27]. Available from: https://www.whitehouse.gov/briefings-statements/remarks-president-trump-vice-president-pence-members-coronavirus-task-force-press-briefing-19/
- Joob B, Wiwanitkit V. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment. Ann Rheum Dis. 2020 Jun;79(6):e61.
- Gianfrancesco MA, Hyrich KL, Gossec L, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020 May; 2(5): e250–e253. Published online 2020 Apr 16. doi: 10.1016/S2665-9913(20)30095-3
- Konig MF, Kim AH, Scheetz MH, et al. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. 2020 May 7:annrheumdis-2020-217690. doi: 10.1136/annrheumdis-2020-217690.
- Mathian A, Mahevas M, Rohmer J, et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis. 2020 Jun;79(6):837–839.
- Lane JCE, Weaver J, Kostka K, et al. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. 2020. [cited 2020 May 28]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.08.20054551v2
- Mercuro NJ, Yen CF, Shim DJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 May 1;e201834. doi: 10.1001/jamacardio.2020.1834.
- Saleh M, Gabriels J, Chang D, et al. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662.
- Bessiere F, Roccia H, Deliniere A, et al. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA Cardiol. 2020 May 1;e201787. doi: 10.1001/jamacardio.2020.1787.
- Chorin E, Wadhwani L, Magnani S, et al. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Heart Rhythm. 2020May 12;S1547-5271(20)30435-5. doi: 10.1016/j.hrthm.2020.05.014.
- Magagnoli J, Narendran S, Pereira F, et al. Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19. Med. 2020 Apr 21;2020.04.16.20065920. doi: 10.1101/2020.04.16.20065920.
- Cohen E, Nigam M Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 [Internet]. CNN.com; [updated 2020 Apr 21; cited 2020 Apr 21; cited 2020 Apr 21; cited 2020 May 21; cited 2020 May 27]. Available from: https://www.cnn.com/2020/04/21/health/hydroxychloroquine-veterans-study/index.html
- Borba MGS, Val FFA, Sampaio VS, et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Network Open. 2020 Apr 24;3(4):e208857.
- COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. National Institutes of Health; 2020 updated 2020 May 12 cited 2020 May 12 cited 2020 May 12 cited 2020 May 12 cited 2020 May 27. Available from: https://www.covid19treatmentguidelines.nih.gov/.
- Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems. [Internet]. [Internet]: U.S. Food and Drug Administration. Drug Safety Communication; 2020, April 24 cited 2020 May 27]. Available from: https://www.fda.gov/safety/medical-product-safety-information/hydroxychloroquine-or-chloroquine-covid-19-drug-safety-communication-fda-cautions-against-use
- Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Jun 18;382(25):2411–2418.
- Rosenberg ES, Dufort EM, Udo T, et al. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA. 2020 May 11;323(24):2493-2502. doi: 10.1001/jama.2020.8630.
- Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020 May;14(369):m1849.
- Mahevas M, Tran VT, Roumier M, et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020;14(369):m1844. May.
- Gearan A, Laurie M, Lenny B, et al. Trump says he is taking hydroxychloroquine to protect against coronavirus, dismissing safety concerns [Internet]: The Washington Post; [updated 2020, May 18]. Available from: https://www.washingtonpost.com/politics/trump-says-he-is-taking-hydroxychloroquine-to-protect-against-coronavirus-dismissing-safety-concerns/2020/05/18/7b8c928a-9946-11ea-ac72-3841fcc9b35f_story.html
- Mehra MR, Desai SS, Ruschitzka F, et al. RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 May 22;S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6.
- WHO Director-General’s opening remarks at the media briefing on COVID-19-25 May 2020 [Internet]. The World Health Organization; 2020 May 25. [cited 2020 May 28]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—25-may-2020
- COVID-19: l’ANSM souhaite suspendre par précaution les essais cliniques évaluant l’hydroxychloroquine dans la prise en charge des patients - Point d’Information. [Internet]: ANSM; [updated 2020 May 26]. Available from: https://www.ansm.sante.fr/S-informer/Actualite/COVID-19-l-ANSM-souhaite-suspendre-par-precaution-les-essais-cliniques-evaluant-l-hydroxychloroquine-dans-la-prise-en-charge-des-patients-Point-d-Information
- Haut Conseil de la Santé Publique. Covid-19: utilisation de l’hydroxychloroquine [Internet]. Paris: Haut Conseil de la Santé Publique; [updated 2020 Mar 26; cited 2020 Mar 26; cited 2020 Mar 26; cited 2020 Jun 26; cited 2020 Jun 25]. Available from: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=837
- Blamont M, Smout A, Parodi E EU governments ban malaria drug for COVID-19, trial paused as safety fears grow [Internet]. Reuters; [updated 2020 May 27; cited 2020 May 27; cited 2020 May 27; cited 2020 Jun 27; cited 2020 Jun 25]. Available from: https://www.reuters.com/article/health-coronavirus-hydroxychloroquine-fr/eu-governments-ban-malaria-drug-for-covid-19-trial-paused-as-safety-fears-grow-idUSKBN2340A6
- Outbreak Brief 13: COVID-19 Pandemic – 14 April 2020 [Internet]. [ Africa CDC; Outbreak Briefs]. [cited 2020 May 28]. Available from: https://africacdc.org/download/outbreak-brief-number-13-covid-19-pandemic-14-april-2020/
- Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 Jun 13;395(10240):1820.
- Mehra MR, Desai SS, Kuy S, et al. Retraction: cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020 Jun 25;382(26):2582. .
- Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Jun 3;NEJMoa2016638. doi: 10.1056/NEJMoa2016638.
- Balasubramanian S Zinc: no Evidence Yet To Support Its Effects On Coronavirus. [Internet]. Forbes.com; [updated Apr 10, 2020; cited 2020; cited 2020 Apr 10, 2020; cited 2020 Jun 10, 2020; cited 2020 Jun 27]. Available from: https://www.forbes.com/sites/saibala/2020/04/10/zinc-no-evidence-yet-to-support-its-effects-on-coronavirus/#d1e173c41513
- P H. Statement from the Chief Investigators of the Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial on hydroxychloroquine: university of Oxford; [updated 5 Jun 2020; 2 2020 Jun 5]. Available from: https://www.recoverytrial.net/files/hcq-recovery-statement-050620-final-002.pdf
- U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine [Internet]; [updated Jun 15, 2020]; FDA News Release 2020 Jun 15]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and
- Update on hydroxychloroquine and the Solidarity Trial - 27 May 2020. [Internet]. World Health Organization; [ updated 2020 Jun 17]; Rolling updates on coronavirus disease (COVID-19)]. [cited 2020 May 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
- Cochrane Response. Targeted Update: safety and efficacy of hydroxychloroquine or chloroquine for treatment of COVID-19. In: the COVID-NMA project, editor: Cochrane Response; 2020. p. 18.
- NIH halts clinical trial of hydroxychloroquine. [Internet]. National Institutes of Health; 2020 Jun 20 [cited 2020 Jun 25]. Available from: https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine
- Kalil AC. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics. JAMA. 2020 Mar 24. doi: 10.1001/jama.2020.4742.
- Rocco F. The miraculous fever tree: malaria and the quest for a cure that changed the world. 1st ed. New York, NY: HarperCollins; 2003.
- Gordon I The chloroquine chronicles: A history of the drug that conquered the world. [Internet]. The World from PRX; [ updated April 15, 2020]. [cited 2020 May 28]. Available from: https://www.pri.org/stories/2020-04-15/chloroquine-chronicles-history-drug-conquered-world
- Spinney L What the 1918 flu pandemic can teach us about coronavirus drug trials. [Internet]. The Guardian; [ updated Apr 5, 2020]. Available from: https://www.theguardian.com/commentisfree/2020/apr/05/1918-flu-pandemic-coronavirus-drug-trials-scientists-treatments-evidence
- Honigsbaum M. Living with enza: the forgotten story of Britain and the great flu pandemic of 1918. London; New York: Macmillan; 2009.
- London AJ, Kimmelman J. Against pandemic research exceptionalism. Science. 2020 May 1;368(6490):476–477.